News About: Pharm. Industry


Mr. Rob Smith named CEO of Lilly Korea.

Mr. Rob Smith was nominated as the chief executive officer of E. Lilly Korea effective from Sept. 1 this year. He graduated from Bradford University in UK in 1979 majoring appli...

Domestic pharmaceutical industry likely to find momentum in third quarter

Korean pharmaceutical industry is expected to gain momentum in the third quarter of this year due to favorable internal factors, said a local analyst in a pharmaceutical report. The report said that investors will...

Drug industry to put more weight on pharmacy business.

To improve the management and business profits, the drug industry tried to expand their business volume more in the retail pharmacy market. Despite the current general economy slow the pharmaceutical business has a...

Pediatric Singulair use recommended

MSD Korea said that it has launched Singulair (montelukast sodium) 4 mg granule for the prevention and treatment of asthma and allergic rhinitis in children. Singulair granule, a tasteless powder form, is a once-a-...

Yuyu wins EU patent for anti-dementia agent

Yuyu Pharm said it has won a patent from European Union for its novel pharmaceutical composition containing selegiline and gingko biloba extract for the treatment of dementia, following the acquisition of the Korea pa...

Hanmi seeking global sales plan for Amodipine.

An explanatory meeting for amlodipine generic drugs was arranged by Hanmi following Chonkundang for 20 members of "Thursday Club", a wholesaler's club, in presence of other 3 city and provincial wholesale association ...

Green Cross and Green Cross BC to merge.

Green Cross announced on Aug. 26 that its subsidiary Green Cross BC, a consulting company, and Green Cross Medical Engineering would be merged after completing their business registration. Green Cross currently ...

First-version generics predicted to exceed 30-70% of domestic pharmaceutical market

Pharmaceutical business sources said that Korean first-version generic drugs, such as amlodipine and glimepiride, may make up more than 30 to 70 percent in less than 10 years, thanks to local doctors' changed percepti...

Generic drugs beneficial to local clinic markets.

By taking occasion for the glimepiride and amlodipine generic drugs to launch in Sept. many pharmaceutical firms would try to concentrate their marketing activities into the private clinic markets, which may give a lo...

Pharmaceutical firms face damage suit over cold remedies

Recently, six Korean people filed a 500 million won damage suit against the government and some cold drug makers, claiming they had suffered side effects from medicines containing phenylpropanolamine (PPA), which alle...

Most Read News


April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
SunMonTueWedThuFriSat
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.